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1. Introduction 
Amytal, rotenone and piericidin A are inhibitors 
of the mitochondrial respiratory chain, blocking 
the oxidation of NADH-dehydrogenase by CoQ~o 
but not by K3Fe(CN)6 [1]. Piericidin A, the most 
potent inhibitor, reacts with the respiratory chain at 
various ites, from all but one it is removed by washing 
with 2% BSA leaving the inhibitor only at electron 
exit port of the NADH dehydrogenase [ 1 ], a site 
defined as the specific binding site [2]. It was later 
shown that there are two non-identical specific binding 
sites per membrane bound enzyme molecule [3], 
differentiated by their reactivity with mersalyl [4]. 
These two sites were attributed to the electron exit 
ports, each' contributes differently to the overall flux 
and differ in the piericidin binding constant [3,4]. 
The average dissociation constant from the two sites 
was estimated as K d = 3.9.10 -1° M [5]. The site of 
inhibition is functionally close to Fe-S center 2 and 
does not prevent energy linked reaction in the 
enzyme [6,7]. Thus reverse lectron transport can be 
observed isolated from redox reaction of CoQlo. The 
similarity in structure of piericidin A and CoQ was 
always tempting to associate it with the inhibition 
mechanism. Yet, the different structure of rotenone 
and amytal, all inhibiting at the same site [2], exclude 
Abbreviations: ETP H, Phosphorylating submitochondrial 
particles; CoQ, Ubiquinone; UC3, ubicidin 3; BSA, Bovine 
serum albumin; PA, piericidin A. 
this possibility. Because of that, the competitive 
relationship between piericidin and CoQlo was 
attributed to competition on the inhibitory and not 
on the substrate site [5]. 
The recently synthetic products, ubicidins, (table 1) 
of Professor H. Rappaport and his colleagues, University 
of California, Berkely, combining the piericidin ring 
structure and the isoprenoid side chain of CoQ, are 
an excellent tool for studying the quinone reducing 
side of NADH-dehydrogenase. In this preliminary 
note we shall show that they share the same site 
with piericidin, a site different from the COQlo 
reducing one. Future use of these inhibitors is dis- 
cussed. 
2. Materials and methods 
Beef heart mitochondria were made according to 
Ringler et al. [8]. ETP n according to Hansen and 
Smith [9]. Ubicidins were a generous gift of 
H. Rappaport, University of California, Berkely. The 
naming of ubicidins follows the nomenclature common 
for the quinone family denoting the number of iso- 
prenoide units in the chain. 
NADH oxidase was measured as described as before 
[3]. Labelling of specific sites carried by adding the 
inhibitor to ETP H suspended in 0.25 M sucrose, 
10 mM K-phosphate, pH 7.4, containing 2% bovine 
serum albumin/ml. After 30 rain equilibrium at 30°C, 
the particles were spun down and washed again by 
the same buffer. 
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3. Results and discussion 
3.1. Inhibition by ubicidins 
In the absence of BSA the pyridone derivatives 
inhibit NADH oxidase in the order piericidin A > 
ubicidin 3 > ubicidin 2 >> ubicidin 4 = ubicidin 
10 >> ubicidin 1. In order to avoid interaction with 
inhibitor at non-specific sites the titrations were 
repeated in the presence of 2% BSA [2]. It was 
noted that BSA lowered a little the inhibition level 
both for piericidin and the ubicidins, reflecting both 
inhibition at the non-specific sites and adsorption 
of inhibitor on BSA [3]. The results of titrations 
where only specific inhibition is measured are 
presented (as a Hill plot) in fig. 1. As seen from the 
figure and documented also in table 1, ubicidin 3 
and ubicidin 2 inhibits the enzyme to 50% (/so) at an 
inhibitor/enzyme ratio very close to that of piericidin 
A. Shorter or longer analogues are 2 and 3 orders of 
magnitude l ss effective. Was the inhibition a result 
of interaction at the CoQ~o binding site one would 
expect ubicidin 10 with side-chain identical with 
CoQ~o to be the most potent inhibitor. The finding 
that inhibition potency peak at side-chain length 
which resembles that of piericidine A, suggests that 
the inhibitors hare a site different from CoQ~o 
reducing sites. Being most potent, ubicidin 3 was 
employed in the rest of the experiments for com- 
parison with piericidin A. 
3.2. Additivity of inhibition 
Additivity of inhibition by ubicidin 3 and piericidin A 
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Fig.1. Hill plot for inhibition of NADH by piericidin A and 
its analoges. Determination f NADH oxidase activity and 
labeling at specific sites were carried out as described inMaterials 
and methods. (a) Piericidin A; (o) ubicidin 3; (=) ubicidin 2; 
(e) ubicidin 4 (D) ubicidin 10; (A) ubicidin 1. 
was measured to determine whether the two inhibitors 
react with the same site. If both react in a mutually 
exclusive way with the same site, inhibition should be 
additive. Where the two inhibitors reacting indepen- 
dently with different sites, the resulting inhibition 
should be less than additive. As shown in table 2, the 
inhibition is additive. The values predicted for two 
Table 2 
Additivity of inhibition of NADH oxidase by piericidin A and ubicidin 3 
Piericidin A Ubicidin 3 AI 
nmol/mg IpA nmol/mg lob s (lob s - IpA) Ipredic t 
40 23% 70 50% 27% 42% 
60 43% 70 68% 25% 57% 
80 51% 70 76% 25% 63% 
120 57% 70 90% 23% 67% 
- - 70 25% - - 
ETP H were labeled at specific sites by increasing piericidin A concentration. After 
equilibration (30 min at 30°C) and determination f inhibition level (IpA), 
constant amount of ubicidin 3 (70 mmol/mg) were added. The inhibit[off m 
presence of the two inhibitors (lob s) was measured after additional equilibrium 
period. The inhibition predicted (Ipredic t) for two independent binding sites is: 
Ipredic t = IpA + IUC 3 - IpA.IUC 3 whereIpA and IUC 3 are inhibition levels 
measured for Piericidin and ubicidin 3 respectively at the given concentration 
(Iuc 3 = 25%). 
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sites deviates markedly from Iobs. Thus we conclude 
that the two inhibitors react with the same site. 
3.3. Mutual displacement of piericidin and ubicidin 3 
In absence of radio-labelled ubicidin 3, the inter- 
action of piericidin and ubicidin 3 with the enzyme 
was measured as binding of [14C] piericidin and the 
effect of ubicidin 3 on the amount bound. 
The most direct experiment is to displace [14C]- 
piericidin by ubicidin 3 from the specific binding site. 
Even 5000 pmol ubicidin 3/mg (30 Iso/mg) for 30 min, 
at 30°C failed to release any [14C]piericidin from the 
specific sites. This lack of displacement means either 
that different binding sites are involved or, that the 
lack of release is due to kinetic reasons. The dissocia- 
tion constant of piericidin from its specific site 
(3-9.10 -1° M)is small enough to make the dissocia- 
tion extremely slow, essentially irreversible, reaction. 
In order to evaluate the kinetic factor, we tried to 
displace [14C]piericidin by un-labelled piericidin 
(30 Iso/mg). No exchange was noted, after 30 min at 
30°C, suggesting that if such a reaction proceeds, it
must be extremely slow. This also accounts for the 
lack of displacement of piericidin A by ubicidin 3. 
An analogous case should be mentioned: 
Klingenberg et al. could not measure any exchange 
between bound and free [3SS]carboxyatractilate 
(K d = 10 -8 M), while the more loosely bound 
atractilate (K d = 5.10 -8 M) was suitable for such 
exchange [ 10]. 
3.4. Estimation of binding constant of ubicidin 3 
To avoid kinetic difficulties, the ETP H were first 
titrated by ubicidin 3 (30 min, 30°C) and then 
challenged by a constant amount of [14C]piericidin. 
After additional equilibration period (30 min, 30°C) 
the particles were spun down, washed by BSA and 
[14C]piericidin bound to specific sites was determined. 
Assuming two independent equilibria of the two 
inhibitors with the same site, 
(E. PAn) 
KE. PA - 
(E) (PA) n 
(E. UC3m) 
KEUC3 - 
(E) (UC3) m 
than at saturating conditions where Efree = 0, it can 
be shown that, 
(E. PA) i 
log 
(E. PA)T - (E. PA)i 
KE. PA n piericidin 
log - -  + - -  log 
m ubicidin 3 KE. UC3 
((E. PA)T and (E. PA)i are the amounts of [14C]- 
piericidin specifically bound at ubicidin 3 = 0 and 
ubicidin 3 = i, respectively). 
The experimental results given in fig.2 fit a straight 
line with a slope of 1 ; meaning that there is no cooper- 
ativity in the binding of each of the two inhibitors. 
The concentration ratio which lowered the piericidin 
binding to 50% and the slope of the line allows to 
estimate the value of KE. pA/KE. UC3" The ratio 
obtained is 0.06, taking KE. PA = 3-9.10 -1° M, we 
estimate KE. UC3 = 0.5-1.5.10 -9 M. The number of 
piericidin binding sites per enzyme is 2. As ubicidin 3 
can block more than half of the binding sites, we must 
conclude that it reacts with at least these two sites, 
most probably m = n = 2. 
3.5. Comparison oflso and K d 
There is a discrepancy between the ratios of inhibi- 
KE PA (uv~)Iso~PA and dissociation ~E.  UC3 constants tion 
being 3 and 16, respectively. This discrepancy is an 
apparent one. Even in the case of piericidin the correla- 
tion between binding and inhibition is sigmoidal [3]. 
As there is no cooperativity in inhibition (fig. 1) or 
binding (fig.2) of the two inhibitors, the sigmoidal 
dependence of inhibition on binding (specific) is due 
to small differences in K d and intrinsic electron flux 
of the two sites. Thus, the differences between binding 
and inhibition observed for ubicidin 3 are similar in 
nature to those reported for piericidin. 
We can summarize that the newly synthesized 
inhibitor ubicidin 3 is very similar in nature to piericidin 
A: (1) It inhibits at molar ratio similar to piericidin; 
(2) The inhibition is not released by BSA washing; 
(3) the inhibition by piericidin and ubicidin 3 is 
additive and; (4) ubicidin 3 can prevent binding of 
piericidin. 
The new family of inhibitors (table 1) displays a 
typical correlation between the length of the side 
chain and inhibition potency, reaching amaximum at 
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Fig.2. Effect of ubicidin 3 on binding of [~4C]piericidin A to specific binding sites. ETPH were treated by increasing ubicine 3 
concentration i 2% BSA sucrose phosphate buffer 30 min 30°C. [14C]piericidin A was added and after 30 min 30°C ETPH 
were spun down washed by BSA and [~4C]piericidin A content determined by scintillation counting. The function drawn in 
the figure is explained in the text. Different symbols are for different experiments. 
chain-length resembling that of piericidin. The tight- 
ness of the binding of piericidin is so high that it is 
not suitable for observing minor changes in the 
binding site (to be monitored as exchange or immobili- 
zation of spin labelled derivatives). The new ubicidins 
offer a wide range of dissociation constants, one or 
few will be suitable for measuring conformational 
changes of the enzyme (or the lipid component of 
the site) [ 11 ], by one of the techniques described 
above. As the binding site is in close proximity to the 
first coupling site [7,8], a tool for close observation 
of enzyme-membrane i teraction of specific loci in 
immediate proximity to coupling site might be at 
hand. 
Finally we wish to propose a novel explanation to 
the bizarre effect of CoQ3 on the respiratory system. 
On one hand it can restore NADH and succinate 
oxidase activity in CoQ-depleted preparations [12], 
on the other hand it inhibits NADH oxidase but not 
succinoxidase activity [ 13]. The site of inhibition 
must be very similar to piericidin as it blocks reduc- 
tion of CoQ, but not of K3Fe(CN)6 [13]. If one 
regards the similarity between CoQa and ubicidin 3 
then these facts are self explained. Apparently, CoQ3 
reacts both with the piericidin, ubicidin sites as 
inhibitor and with the CoQ reducing site as electron 
acceptor. It is the superposition of these antagonistic 
effects which blurred the observations. 
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